Dr. Paul A Schmidt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 507 Sw Big Bend Trl, Glen Rose, TX 76043 Phone: 254-897-3444 Fax: 254-897-9973 |
Dr. Steven J Vacek, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 409 Glenwood St, Suite 500, Glen Rose, TX 76043 Phone: 254-897-2202 Fax: 254-897-1638 |
Josie Lopez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 409 Glenwood St Ste 500, Glen Rose, TX 76043 Phone: 254-897-2202 Fax: 844-659-3800 |
Karen Burroughs, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1021 Holden St Ste 200, Glen Rose, TX 76043 Phone: 254-897-3310 Fax: 844-539-4912 |
Albert Jay Turk, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 409 Glenwood St Ste 500, Glen Rose, TX 76043 Phone: 254-897-2202 Fax: 254-897-2102 |
Dr. Mark W Schneider, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 507 Sw Big Bend Trl, Ste J, Glen Rose, TX 76043 Phone: 254-898-0224 Fax: 254-898-0229 |
Dr. Michael L Davis, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 409 Glenwood St, 500, Glen Rose, TX 76043 Phone: 254-897-3369 Fax: 254-898-1157 |
News Archive
Applied NeuroSolutions, Inc.(www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today confirmed, as previously disclosed in July 2009, that it has achieved sufficient analytical sensitivity to detect tau in serum patient samples.
iTech Medical, Inc., a medical information technology company, announced today that it has received Health Canada approval for the Company's Muscle Pattern Recognition (MPR) System, a non-invasive clinical assessment tool being developed to assist in the diagnosis and treatment of back and neck pain, one of the most common chronic conditions in Canada.
Genentech, a member of the Roche Group, announced today that people with HER2-positive metastatic breast cancer (mBC) lived significantly longer (overall survival) when treated with the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy, compared to Herceptin and docetaxel chemotherapy alone in the Phase III CLEOPATRA study.
Short sleep times, experienced by many individuals in Westernized societies, may contribute to the development of insulin resistance and reduced glucose tolerance, which in turn may increase the long-term risk of diabetes, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
› Verified 2 days ago